We reshaped the portfolio, including divesting a number of non-core businesses. Following the sale of Validus Re in November of 2023, we closed on the sale of the global individual personal travel insurance business in December of 2024 to further position us for the future.

Feb 12, 2025 / CEO / receipt, needs a key / Peter Zafino, CEO | earnings call 2025-02-12 | transcript ca99df6a-1705-49f7-954d-295c3ee5cd1f | chars 5722-5996 | segment 5

North America personal net premiums written increased 17%. primarily driven by lower quota share sessions in PCG, offset by decreases in travel and warranty.

Aug 2, 2023 / CEO / receipt, needs a key / Peter Zafino, CEO | earnings call 2023-08-02 | transcript cab281a6-8404-476d-a212-574b12004887 | chars 17033-17190 | segment 17

In international personal, net premiums written slightly increased by 1% on an FX-adjusted basis due to a rebound in travel and growth in A&H.

Feb 16, 2023 / CEO / receipt, needs a key / Peter Zafino, CEO | earnings call 2023-02-16 | transcript a74ce0c5-e107-4dc8-9d82-f9102a3d03e9 | chars 6464-6606 | segment 6

This was primarily due to our decision to strategically reposition our high net worth business to syndicate 2019, the partnership we established with Lloyd's, which resulted in higher seeded premium and the impact of COVID-19 on lines such as travel and accident health.

Feb 17, 2021 / CEO / receipt, needs a key / Peter Zafino, CEO | earnings call 2021-02-17 | transcript 118ce824-0211-4e5d-add0-b14202be1aac | chars 11430-11700 | segment 11